<![CDATA[Identifying Uses for Immunotherapy Across Sarcoma Populations and Subtypes]]>

Summary: Immunotherapy hasn't always worked well for a type of cancer called sarcoma. But doctors are finding exciting new ways to use it! Dr. Steven Bialick explains that a specific type of sarcoma responds very well to an immunotherapy drug called atezolizumab.

Also, doctors can use special tests to find tumors with a unique feature called MSI-H. If a patient has an MSI-H tumor, they might be able to take an immunotherapy drug like pembrolizumab, even if they are too sick or old for regular chemotherapy. This is why testing the tumor's genes is so important to find the right treatment.

For more details, see cancernetwork at cancernetwork.com/view/identifying-uses-for-immunotherapy-across-sarcoma-populations-and-subtypes (opens in new tab)